{
    "title": "Pfizer drug effective in patients with rare lung cancer -study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2771772/Pfizer-drug-effective-patients-rare-lung-cancer-study.html",
    "date": "2014-09-27",
    "keywords": [
        "lung",
        "cancer",
        "study",
        "percent",
        "gene",
        "mutation",
        "ros1",
        "treatment",
        "tumor",
        "drug",
        "gmt",
        "september",
        "bill",
        "meeting",
        "nonsmall",
        "cell",
        "crizotinib",
        "activity",
        "center",
        "iafrate",
        "email",
        "form",
        "disease",
        "saturdayin",
        "rearrangement",
        "shrinkage",
        "growth",
        "alk",
        "companion",
        "test",
        "result",
        "fusion",
        "crizotinibs",
        "group",
        "fide",
        "target",
        "lead",
        "investigator",
        "massachusetts",
        "hospital",
        "boston",
        "duration",
        "response",
        "half",
        "evidence",
        "progression",
        "resistance",
        "average",
        "melanoma",
        "saidthe",
        "society",
        "oncology",
        "esmo",
        "madrid",
        "journal",
        "understanding",
        "mutationthis",
        "example",
        "success",
        "medicine",
        "john",
        "director",
        "studys",
        "nsclc",
        "laboratory",
        "differencexalkori",
        "patientspfizer",
        "research",
        "population",
        "company",
        "yearreporting",
        "berkrot",
        "dan",
        "grebler"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}